Results 81 to 90 of about 36,735 (203)
The levels of nitric oxide in beta-thalassemia minor
OBJECTIVE: The aim of this study was to investigate the relationship between NO (nitric oxide) and beta-thalassemia minor. METHODS: A total of 60 patients with beta-thalassemia minor (30 M, 30 F) were included in the study. The control group consisted of
Yalçın Başaran +3 more
doaj
ABSTRACT Hydroxyurea (HU) is the most widely prescribed disease‐modifying treatment in sickle cell disease (SCD), though treatment responses vary due to metabolism and adherence. We examined HU blood levels and treatment response in patients with homozygous sickle cell disease (HbSS).
Sigrid van der Veen +26 more
wiley +1 more source
Non-invasive prenatal diagnosis of beta-thalassemia disease using digital PCR
IntroductionTo evaluate the performance of digital polymerase chain reaction (dPCR) as a non-invasive prenatal test (NIPT) for assessing the risk of the fetus being affected by beta-thalassemia major and beta-thalassemia/Hb E disease.MethodsThis cross ...
Chalit Tangwerapornpong +7 more
doaj +1 more source
Beta thalassemia major is an inherited disease resulting from reduction or total lack of beta globin chains. Patients with this disease need repeated blood transfusion for survival.
Q. Shazia +3 more
doaj +1 more source
Smart Design: Integrating Artificial Intelligence and Gene Editing for Advanced mRNA Therapeutics
The challenges of mRNA therapy and the application of artificial intelligence and gene editing in the field of mRNA drugs. ABSTRACT Artificial intelligence (AI) and gene editing are increasingly being applied to the design and evaluation of mRNA therapeutics.
Haixing Shi +11 more
wiley +1 more source
Glioma cells mainly express the endothelin receptor EDNRB, while EDNRA is restricted to a perivascular tumor subpopulation. Endothelin signaling reduces glioma cell proliferation while promoting migration and a proneural‐to‐mesenchymal transition associated with poor prognosis. This pathway activates Ca2+, K+, ERK, and STAT3 signalings and is regulated
Donovan Pineau +36 more
wiley +1 more source
ABSTRACT Diamond–Blackfan Anemia Syndrome (DBAS) is a rare congenital anemia often requiring chronic red blood cell transfusions from infancy. Without appropriate chelation, iron overload develops early and may be severe; however, no data are available on chelation in patients under 3 years of age.
Francesca Torchio +19 more
wiley +1 more source
Beta Thalassemia and Chronic Myeloid Leukemia: Dual Diagnosis Under the Microscope
International Journal of Laboratory Hematology, EarlyView.
Paige Muir +3 more
wiley +1 more source
ABSTRACT Exagamglogene autotemcel (exa‐cel) is a one‐time, ex vivo, CRISPR‐Cas9 gene edited cell therapy approved for patients with transfusion dependent β‐thalassemia (TDT) aged 12–35 years. In a Phase 3 study (CLIMB THAL‐111), exa‐cel treatment resulted in reactivation of fetal hemoglobin and increases in total hemoglobin, leading to transfusion ...
Sujit Sheth +25 more
wiley +1 more source
ABSTRACT Background Knowledge, attitudes, and practices (KAP) studies provide essential insight into public awareness, perceptions, and behaviors toward health issues. Hepatitis B virus (HBV) remains a major public health problem in Jordan. Transfusion‐dependent patients are at higher risk of infection due to frequent exposure to blood products.
Nader Alaridah +11 more
wiley +1 more source

